{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T05:17:03Z","timestamp":1778217423527,"version":"3.51.4"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:00:00Z","timestamp":1725408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["SCU2022F4080"],"award-info":[{"award-number":["SCU2022F4080"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-71549-2","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T03:35:17Z","timestamp":1725420917000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Establishment of cutoff values for anti-\u03b22 glycoprotein I antibodies in women of reproductive age in Southwest China"],"prefix":"10.1038","volume":"14","author":[{"given":"Chenxi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingyi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menglan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Gou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifei","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongmei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leiwen","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wensheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,4]]},"reference":[{"issue":"2","key":"71549_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis, S. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J. Thromb. Haemost. 4(2), 295\u2013306. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01753.x (2006).","journal-title":"J. Thromb. Haemost."},{"issue":"10","key":"71549_CR2","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1136\/ard-2023-224609","volume":"82","author":"M Barbhaiya","year":"2023","unstructured":"Barbhaiya, M. et al. 2023 ACR\/EULAR antiphospholipid syndrome classification criteria. Ann. Rheum. Dis. 82(10), 1258\u20131270. https:\/\/doi.org\/10.1136\/ard-2023-224609 (2023).","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"71549_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/jth.13976","volume":"16","author":"KMJ Devreese","year":"2018","unstructured":"Devreese, K. M. J., Ortel, T. L., Pengo, V. & de Laat, B. Laboratory criteria for antiphospholipid syndrome: Communication from the SSC of the ISTH. J. Thromb. Haemost. 16(4), 809\u2013813. https:\/\/doi.org\/10.1111\/jth.13976 (2018).","journal-title":"J. Thromb. Haemost."},{"issue":"5","key":"71549_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.autrev.2015.01.002","volume":"14","author":"MM Abreu","year":"2015","unstructured":"Abreu, M. M. et al. The relevance of \u201cnon-criteria\u201d clinical manifestations of antiphospholipid syndrome: 14th International congress on antiphospholipid antibodies technical task force report on antiphospholipid syndrome clinical features. Autoimmun. Rev. 14(5), 401\u2013414. https:\/\/doi.org\/10.1016\/j.autrev.2015.01.002 (2015).","journal-title":"Autoimmun. Rev."},{"issue":"1","key":"71549_CR5","doi-asserted-by":"publisher","first-page":"102913","DOI":"10.1016\/j.autrev.2021.102913","volume":"21","author":"I Bernardoff","year":"2022","unstructured":"Bernardoff, I. et al. Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis. Autoimmun. Rev. 21(1), 102913. https:\/\/doi.org\/10.1016\/j.autrev.2021.102913 (2022).","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"71549_CR6","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1111\/ijlh.12234","volume":"36","author":"KM Devreese","year":"2014","unstructured":"Devreese, K. M. Antiphospholipid antibody testing and standardization. Int. J. Lab. Hematol. 36(3), 352\u2013363. https:\/\/doi.org\/10.1111\/ijlh.12234 (2014).","journal-title":"Int. J. Lab. Hematol."},{"issue":"6","key":"71549_CR7","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/pat.0000000000000142","volume":"46","author":"EJ Favaloro","year":"2014","unstructured":"Favaloro, E. J. & Wong, R. C. Antiphospholipid antibody testing for the antiphospholipid syndrome: A comprehensive practical review including a synopsis of challenges and recent guidelines. Pathology 46(6), 481\u2013495. https:\/\/doi.org\/10.1097\/pat.0000000000000142 (2014).","journal-title":"Pathology"},{"issue":"3","key":"71549_CR8","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1515\/cclm.2011.064","volume":"49","author":"EJ Favaloro","year":"2011","unstructured":"Favaloro, E. J. & Wong, R. C. Laboratory testing for the antiphospholipid syndrome: Making sense of antiphospholipid antibody assays. Clin. Chem. Lab. Med. 49(3), 447\u2013461. https:\/\/doi.org\/10.1515\/cclm.2011.064 (2011).","journal-title":"Clin. Chem. Lab. Med."},{"issue":"9","key":"71549_CR9","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1177\/0961203318776105","volume":"27","author":"MV Bor","year":"2018","unstructured":"Bor, M. V., Jacobsen, I. S., Gram, J. B. & Sidelmann, J. J. Revisiting the Phadia\/EliA cut-off values for anticardiolipin and anti-\u03b22-glycoprotein I antibodies: A systematic evaluation according to the guidelines. Lupus 27(9), 1446\u20131454. https:\/\/doi.org\/10.1177\/0961203318776105 (2018).","journal-title":"Lupus"},{"key":"71549_CR10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.imlet.2017.03.013","volume":"186","author":"A Bai","year":"2017","unstructured":"Bai, A. \u03b22-glycoprotein I and its antibodies involve in the pathogenesis of the antiphospholipid syndrome. Immunol. Lett. 186, 15\u201319. https:\/\/doi.org\/10.1016\/j.imlet.2017.03.013 (2017).","journal-title":"Immunol. Lett."},{"issue":"1","key":"71549_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/bf02686083","volume":"32","author":"PL Meroni","year":"2007","unstructured":"Meroni, P. L. et al. Role of anti-beta2 glycoprotein I antibodies in antiphospholipid syndrome: In vitro and in vivo studies. Clin. Rev. Allergy Immunol. 32(1), 67\u201374. https:\/\/doi.org\/10.1007\/bf02686083 (2007).","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"6","key":"71549_CR12","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.thromres.2011.04.021","volume":"128","author":"A Banzato","year":"2011","unstructured":"Banzato, A. et al. Antibodies to domain I of \u03b2(2)glycoprotein I are in close relation to patients risk categories in antiphospholipid syndrome (APS). Thromb. Res. 128(6), 583\u2013586. https:\/\/doi.org\/10.1016\/j.thromres.2011.04.021 (2011).","journal-title":"Thromb. Res."},{"key":"71549_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/ijlh.13195","volume":"42","author":"KMJ Devreese","year":"2020","unstructured":"Devreese, K. M. J. Testing for antiphospholipid antibodies: Advances and best practices. Int. J. Lab. Hematol. 42, 49\u201358. https:\/\/doi.org\/10.1111\/ijlh.13195 (2020).","journal-title":"Int. J. Lab. Hematol."},{"key":"71549_CR14","unstructured":"World Health Organization. Women of reproductive age (15\u201349\u00a0years) population (thousands). https:\/\/www.who.int\/data\/gho\/indicator-metadata-registry\/imr-details\/women-of-reproductive-age-(15-49-years)-population-(thousands) (2024)."},{"issue":"7","key":"71549_CR15","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1515\/cclm-2012-0421","volume":"51","author":"K Ichihara","year":"2013","unstructured":"Ichihara, K. et al. The Asian project for collaborative derivation of reference intervals: (1) strategy and major results of standardized analytes. Clin. Chem. Lab. Med. 51(7), 1429\u20131442. https:\/\/doi.org\/10.1515\/cclm-2012-0421 (2013).","journal-title":"Clin. Chem. Lab. Med."},{"key":"71549_CR16","unstructured":"ISO 15189:2022. Medical laboratories\u2014Requirements for quality and competence. https:\/\/www.iso.org\/standard\/76677.html (2022)."},{"key":"71549_CR17","unstructured":"Clinical and Laboratory Standards Institute (2015). Defining, establishing, and verifying reference intervals in the clinical laboratory, 3rd edition. CLSI document EP28-A3c. Wayne PA: Clinical and Laboratory Standards Institute. (2015)."},{"issue":"5","key":"71549_CR18","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1111\/jth.12537","volume":"12","author":"KM Devreese","year":"2014","unstructured":"Devreese, K. M. et al. Testing for antiphospholipid antibodies with solid phase assays: Guidance from the SSC of the ISTH. J. Thromb. Haemost. 12(5), 792\u2013795. https:\/\/doi.org\/10.1111\/jth.12537 (2014).","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"71549_CR19","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.thromres.2011.06.023","volume":"128","author":"KM Devreese","year":"2011","unstructured":"Devreese, K. M. & Van Hoecke, F. Anticardiolipin and anti-\u03b22glycoprotein-I antibody cut-off values in the diagnosis of antiphospholipid syndrome: More than calculating the in-house 99th percentiles, even for new automated assays. Thromb. Res. 128(6), 598\u2013600. https:\/\/doi.org\/10.1016\/j.thromres.2011.06.023 (2011).","journal-title":"Thromb. Res."},{"issue":"1","key":"71549_CR20","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/jth.14633","volume":"18","author":"W Chayoua","year":"2020","unstructured":"Chayoua, W. et al. The (non-)sense of detecting anti-cardiolipin and anti-\u03b22glycoprotein I IgM antibodies in the antiphospholipid syndrome. J. Thromb. Haemost. 18(1), 169\u2013179. https:\/\/doi.org\/10.1111\/jth.14633 (2020).","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"71549_CR21","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1177\/0961203310361491","volume":"19","author":"A Tincani","year":"2010","unstructured":"Tincani, A., Andreoli, L., Casu, C., Cattaneo, R. & Meroni, P. Antiphospholipid antibody profile: Implications for the evaluation and management of patients. Lupus 19(4), 432\u2013435. https:\/\/doi.org\/10.1177\/0961203310361491 (2010).","journal-title":"Lupus"},{"key":"71549_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1080\/08820139.2019.1647233","volume":"49","author":"V Grossi","year":"2020","unstructured":"Grossi, V. et al. Two novel technologies for the detection of anti-cardiolipin and anti \u03b22-glycoprotein antibodies in the real life: Chemiluminescent in comparison to the addressable laser bead immunoassays. Immunol. Investig. 49, 58\u201368. https:\/\/doi.org\/10.1080\/08820139.2019.1647233 (2020).","journal-title":"Immunol. Investig."},{"issue":"3","key":"71549_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/rth2.12207","volume":"3","author":"L Vanoverschelde","year":"2019","unstructured":"Vanoverschelde, L., Kelchtermans, H., Musial, J., de Laat, B. & Devreese, K. M. J. Influence of anticardiolipin and anti-\u03b22 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification. Res. Pract. Thromb. Haemost. 3(3), 515\u2013527. https:\/\/doi.org\/10.1002\/rth2.12207 (2019).","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"7","key":"71549_CR24","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1177\/0961203312442260","volume":"21","author":"B Montaruli","year":"2012","unstructured":"Montaruli, B. et al. Anti-cardiolipin and anti-\u03b22-glycoprotein I antibodies: Normal reference ranges in northwestern Italy. Lupus 21(7), 799\u2013801. https:\/\/doi.org\/10.1177\/0961203312442260 (2012).","journal-title":"Lupus"},{"issue":"4","key":"71549_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/clinchem\/17.4.275","volume":"17","author":"AH Reed","year":"1971","unstructured":"Reed, A. H., Henry, R. J. & Mason, W. B. Influence of statistical method used on the resulting estimate of normal range. Clin. Chem. 17(4), 275\u2013284 (1971).","journal-title":"Clin. Chem."},{"issue":"1","key":"71549_CR26","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2307\/3001634","volume":"9","author":"W Dixon","year":"1953","unstructured":"Dixon, W. Processing data for outliers. Biometrics 9(1), 74\u201389 (1953).","journal-title":"Biometrics"},{"key":"71549_CR27","first-page":"688","volume-title":"Exploratory Data Analysis","author":"JW Tukey","year":"1977","unstructured":"Tukey, J. W. Exploratory Data Analysis 688 (Addison-Wesley, 1977)."},{"issue":"12","key":"71549_CR28","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1111\/jth.12732","volume":"12","author":"P Fontana","year":"2014","unstructured":"Fontana, P., Poncet, A., Lindhoff-Last, E., de Moerloose, P. & Devreese, K. M. Refinement of the cutoff values of the HemosIL AcuStar assay for the detection of anticardiolipin and anti-beta2 glycoprotein-1 antibodies. J. Thromb. Haemost. 12(12), 2034\u20132037. https:\/\/doi.org\/10.1111\/jth.12732 (2014).","journal-title":"J. Thromb. Haemost."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71549-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71549-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71549-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T03:36:33Z","timestamp":1725420993000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-71549-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,4]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["71549"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-71549-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,4]]},"assertion":[{"value":"4 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20529"}}